{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:26:19Z","timestamp":1791563179358,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ajog.2016.04.029","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T01:56:41Z","timestamp":1461981401000},"page":"298-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Noninvasive prenatal screening or advanced diagnostic testing: caveat emptor"],"prefix":"10.1016","volume":"215","author":[{"given":"Mark I.","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Wapner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2016.04.029_bib1","series-title":"Technology in\u00a0American health care: policy directions for effective evaluation and management","year":"2004"},{"key":"10.1016\/j.ajog.2016.04.029_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1085-6862(97)00035-6","article-title":"The introduction of new\u00a0technologies","volume":"2","author":"Evans","year":"1997","journal-title":"ACOG Clin Semin"},{"key":"10.1016\/j.ajog.2016.04.029_bib3","series-title":"Prenatal diagnosis","first-page":"289","article-title":"First trimester ultrasound screening with nuchal translucency","author":"Hyett","year":"2006"},{"key":"10.1016\/j.ajog.2016.04.029_bib4","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa043693","article-title":"First trimester or second trimester screening, or both for Down syndrome","volume":"353","author":"Malone","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2016.04.029_bib5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM198903093201001","article-title":"The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities","volume":"320","author":"Rhoads","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2016.04.029_bib6","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1469-8749.2012.04287.x","article-title":"Microdeletions detected using chromosome microarray in children with suspected genetic movement disorders: a single-centre study","volume":"54","author":"Dale","year":"2012","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.ajog.2016.04.029_bib7","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/ajmg.a.35960","article-title":"Customized high resolution CGH-array for clinical diagnosis reveals additional genomic imbalances in previous well-defined pathological samples","volume":"161a","author":"Vallespin","year":"2013","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ajog.2016.04.029_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/mgg3.12","article-title":"Prevalence of selected genomic deletions and duplications in a French-Canadian population-based sample of newborns","volume":"1","author":"Tucker","year":"2013","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.ajog.2016.04.029_bib9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ajhg.2010.04.006","article-title":"Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies","volume":"86","author":"Miller","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajog.2016.04.029_bib10","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1056\/NEJMoa1203382","article-title":"Chromosomal microarray versus karyotyping for prenatal diagnosis","volume":"367","author":"Wapner","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2016.04.029_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/pd.4531","article-title":"Current controversies in prenatal diagnosis 3: the ethical and counseling implications of new genomic technologies: all pregnant women should be offered prenatal diagnostic genome-wide testing for prenatally identified fetal congenital anomalies","volume":"35","author":"Wilson","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2016.04.029_bib12","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1097\/01.AOG.0000438962.16108.d1","article-title":"The use of chromosomal microarray analysis in prenatal diagnosis. Committee opinion no. 581","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib13","doi-asserted-by":"crossref","first-page":"330.e1","DOI":"10.1016\/j.ajog.2014.10.011","article-title":"Karyotype versus genomic hybridization for the prenatal diagnosis of chromosomal abnormalities: a metaanalysis","volume":"212","author":"Saldarriaga","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib14","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/pd.3945","article-title":"Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies","volume":"32","author":"Shaffer","year":"2012","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2016.04.029_bib15","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/uog.14880","article-title":"Genomic microarray in fetuses with increased nuchal translucency and normal karyotype\u2014a systematic review and meta-analysis","volume":"46","author":"Grande","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib16","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/pd.3943","article-title":"Detection rates of clinically significant genomic alterations by microarray analysis for specific anomalies detected by ultrasound","volume":"32","author":"Shaffer","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2016.04.029_bib17","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/pd.4209","article-title":"The clinical utility of microarray technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: a review of the literature","volume":"33","author":"Callaway","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2016.04.029_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/pd.4287","article-title":"Controversies in prenatal diagnosis 3: should everyone undergoing invasive testing have a microarray?","volume":"34","author":"Crolla","year":"2014","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2016.04.029_bib19","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1097\/AOG.0000000000001405","article-title":"Practice Bulletin no. 162. Prenatal diagnostic testing for genetic disorders","volume":"127","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2016.04.029_bib21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/pd.4136","article-title":"Noninvasive prenatal testing: the paradigm is shifting rapidly","volume":"33","author":"Chitty","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2016.04.029_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/uog.12513","article-title":"Non-invasive prenatal testing for aneuploidy: current status and future prospects","volume":"42","author":"Benn","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib23","doi-asserted-by":"crossref","first-page":"205.e1","DOI":"10.1016\/j.ajog.2010.12.060","article-title":"Noninvasive detection of trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting","volume":"204","author":"Ehrich","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib24","doi-asserted-by":"crossref","first-page":"319.e1","DOI":"10.1016\/j.ajog.2012.01.030","article-title":"Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18","volume":"206","author":"Sparks","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib25","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/AOG.0b013e31824fb482","article-title":"Genomewide fetal aneuploidy detection by maternal plasma DNA sequencing","volume":"119","author":"Bianchi","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib26","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/pd.4366","article-title":"Theoretical performance of non-invasive prenatal testing for chromosome imbalances using counting of cell-free DNA fragments in maternal plasma","volume":"34","author":"Benn","year":"2014","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2016.04.029_bib27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1471-0528.2008.02010.x","article-title":"Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art","volume":"116","author":"Lo","year":"2009","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2016.04.029_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.02.030","article-title":"Clinical validation of a noninvasive prenatal test for genomewide detection of fetal number variants","volume":"215","author":"Lefkowitz","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib29","doi-asserted-by":"crossref","first-page":"205.e1","DOI":"10.1016\/j.ajog.2010.12.060","article-title":"Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood; a study in\u00a0a clinical setting","volume":"204","author":"Ehrich","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib30","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1311037","article-title":"DNA sequencing versus standard prenatal aneuploidy screening","volume":"370","author":"Bianchi","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2016.04.029_bib31","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000367626","article-title":"Microarray-based cell free DNA analysis improves noninvasive prenatal testing","volume":"36","author":"Juneaux","year":"2014","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2016.04.029_bib32","doi-asserted-by":"crossref","first-page":"527.e1","DOI":"10.1016\/j.ajog.2014.08.006","article-title":"Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing","volume":"211","author":"Dar","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib33","doi-asserted-by":"crossref","first-page":"20458","DOI":"10.1073\/pnas.0810641105","article-title":"Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma","volume":"105","author":"Chiu","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.ajog.2016.04.029_bib34","doi-asserted-by":"crossref","first-page":"16266","DOI":"10.1073\/pnas.0808319105","article-title":"Noninvasive diagnosis of\u00a0fetal aneuploidy by shotgun sequencing DNA\u00a0from maternal blood","volume":"105","author":"Fan","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.ajog.2016.04.029_bib35","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1097\/AOG.0000000000001406","article-title":"Practice Bulletin no. 163. Screening for fetal aneuploidy","volume":"127","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib36","doi-asserted-by":"crossref","first-page":"79.e1","DOI":"10.1016\/j.ajog.2014.10.012","article-title":"Detection of triploid, molar, and vanishing twin\u00a0pregnancies by a single-nucleotide polymorphism-based noninvasive test","volume":"212","author":"Curnow","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib37","series-title":"Avery\u2019s neonatology: pathophysiology and management of the newborn","first-page":"p113","article-title":"Prenatal diagnosis in the molecular age\u2014indications, procedures, and laboratory techniques","author":"Evans","year":"2016"},{"key":"10.1016\/j.ajog.2016.04.029_bib38","doi-asserted-by":"crossref","first-page":"332.e1","DOI":"10.1016\/j.ajog.2014.11.041","article-title":"Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes","volume":"212","author":"Wapner","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib39","doi-asserted-by":"crossref","first-page":"102.e1","DOI":"10.1016\/j.ajog.2015.04.005","article-title":"Utilization of noninvasive prenatal testing: impact on referrals for diagnostic testing","volume":"213","author":"Williams","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"5 Pt 1","key":"10.1016\/j.ajog.2016.04.029_bib40","article-title":"Nuchal translucency thickness in fetuses with chromosomal translocation at 11\u201312 weeks of gestation","volume":"105","author":"Cheng","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/pd.4054","article-title":"Nearly a third of abnormalities found after first-trimester screening are different than expected: 10-year experience from a single center","volume":"33","author":"Alamillo","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2016.04.029_bib42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ajog.2015.05.004","article-title":"Cell free DNA testing\u2014interpretation of results using an online calculator","volume":"213","author":"Grace","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib43","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.ajog.2013.10.181","article-title":"Increased nuchal translucency and normal karyotype: value of additional testing","volume":"210","author":"Coletta Lucas","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib44","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ajog.2014.10.033","article-title":"Cell free DNA analysis vs sequential screening as primary testing considering all fetal chromosomal abnormalities","volume":"212","author":"Norton","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ajog.2015.05.042","article-title":"Helping providers interpret cell-free fetal DNA testing","volume":"213","author":"Macones","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib46","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1373\/clinchem.2014.233312","article-title":"Detection of fetal subchromosomal abnormalities by sequencing circulating cell-free DNA from maternal plasma","volume":"61","author":"Zhao","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajog.2016.04.029_bib47","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMc1412222","article-title":"Accurate description of DNA-based non invasive prenatal screening","volume":"372","author":"Cheung","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2016.04.029_bib48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/cen.12466","article-title":"Prevalence of hypocalcemia and its associated features in 22q11.2 deletion syndrome","volume":"81","author":"Cheung","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ajog.2016.04.029_bib49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/uog.14636","article-title":"Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis","volume":"45","author":"Akolekar","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib50","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/01.AOG.0000240135.13594.07","article-title":"Pregnancy loss rates after midtrimester amniocentesis","volume":"108","author":"Eddleman","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib51","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/01.AOG.0000232512.46869.fc","article-title":"Chorionic villus sampling compared with amniocentesis and the difference in rate of pregnancy loss","volume":"108","author":"Caughey","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/uog.15820","article-title":"Danish Fetal Medicine Study Group. Risk of fetal loss associated with\u00a0invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147,987 singleton pregnancies","volume":"47","author":"Wulff","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib53","doi-asserted-by":"crossref","DOI":"10.1159\/000442197","article-title":"Incorporating microarrays into routine prenatal diagnosis: determinants of decision making","author":"Cordoba","year":"2016","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2016.04.029_bib54","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.socscimed.2007.06.026","article-title":"Sometimes doing the right thing sucks: frame combinations and multifetal pregnancy reduction decision difficulty","volume":"65","author":"Britt","year":"2007","journal-title":"Social Sci Med"},{"key":"10.1016\/j.ajog.2016.04.029_bib55","doi-asserted-by":"crossref","first-page":"527.e1","DOI":"10.1016\/j.ajog.2014.10.1092","article-title":"Long-term neurologic outcomes after common fetal interventions","volume":"212","author":"Gebb","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib56","doi-asserted-by":"crossref","first-page":"214.e1","DOI":"10.1016\/j.ajog.2015.04.001","article-title":"Non-invasive screening for aneuploidy: positive predictive values based on cytogenetic findings","volume":"213","author":"Meck","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.04.029_bib57","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/gim.2013.29","article-title":"ACMG statement on noninvasive prenatal screening for fetal aneuploidy","volume":"15","author":"Gregg","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.ajog.2016.04.029_bib58","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/14.5.1213","article-title":"International, collaborative assessment of 146,000 prenatal karyotypes: expected limitations if only chromosome-specific probes and fluorescent in\u00a0situ hybridization were used","volume":"14","author":"Evans","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2016.04.029_bib59","doi-asserted-by":"crossref","first-page":"137ra76","DOI":"10.1126\/scitranslmed.3004323","article-title":"Noninvasive whole genome sequencing of a human fetus","volume":"4","author":"Kitzman","year":"2012","journal-title":"Sci Translat Med"},{"key":"10.1016\/j.ajog.2016.04.029_bib60","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/pd.4157","article-title":"Maternal cffDNA screening for Down syndrome\u2014a cost sensitivity analysis","volume":"33","author":"Cuckle","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2016.04.029_bib61","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3109\/14767058.2013.807239","article-title":"Clinical utility and cost of non-invasive prenatal testing","volume":"27","author":"Cuckle","year":"2014","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2016.04.029_bib62","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/uog.14693","article-title":"Optimizing the implementation strategy for cell free fetal DNA screening in the\u00a0United States","volume":"45","author":"Evans","year":"2015","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937816301144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937816301144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:11:52Z","timestamp":1757589112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937816301144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0002937816301144"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2016.04.029","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noninvasive prenatal screening or advanced diagnostic testing: caveat emptor","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2016.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}